GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX3 | hg19_v2_chr12_-_115121962_115121987 | 0.32 | 1.0e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23237555 Show fit | 13.43 |
ENST00000390321.2
|
immunoglobulin lambda constant 1 (Mcg marker) |
|
chr5_-_39425222 Show fit | 11.53 |
ENST00000320816.6
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
|
chr2_-_89310012 Show fit | 11.10 |
ENST00000493819.1
|
immunoglobulin kappa variable 1-9 |
|
chr16_+_55512742 Show fit | 10.21 |
ENST00000568715.1
ENST00000219070.4 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
chr2_-_89266286 Show fit | 9.63 |
ENST00000464162.1
|
immunoglobulin kappa variable 1-6 |
|
chr2_-_89513402 Show fit | 9.49 |
ENST00000498435.1
|
immunoglobulin kappa variable 1-27 |
|
chr14_-_106642049 Show fit | 8.61 |
ENST00000390605.2
|
immunoglobulin heavy variable 1-18 |
|
chr2_-_209118974 Show fit | 8.42 |
ENST00000415913.1
ENST00000415282.1 ENST00000446179.1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
chr6_-_52668605 Show fit | 8.00 |
ENST00000334575.5
|
glutathione S-transferase alpha 1 |
|
chr11_-_327537 Show fit | 7.67 |
ENST00000602735.1
|
interferon induced transmembrane protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 42.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 31.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.9 | 25.0 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
5.1 | 15.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.5 | 11.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
2.9 | 11.5 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
2.0 | 10.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 10.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 9.9 | GO:0042246 | tissue regeneration(GO:0042246) |
2.2 | 8.7 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 82.2 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 31.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 26.0 | GO:0070062 | extracellular exosome(GO:0070062) |
2.1 | 25.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 17.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.3 | 11.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 8.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 7.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 7.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 6.7 | GO:0045095 | keratin filament(GO:0045095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 40.3 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 31.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 27.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
5.1 | 15.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.5 | 11.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 8.7 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 8.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 8.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 7.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 6.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 14.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 11.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 9.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 7.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 6.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 5.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 3.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 25.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 17.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 16.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 14.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 11.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 10.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 10.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 7.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 6.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 6.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |